EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN

EХPERIENCE IN INTERFERON β-1A USE FOR TREATMENT OF MULTIPLE SCLEROSIS IN CHILDREN

Aim: to evaluate the impact of subcutaneous interferon β-1a on matrix metalloproteinases 3, 8, 9 (MMP), cytokines (tumor necrosis factor α — TNF α, and transforming growth factor β1 — TGF β1) levels in serum of children with relapsing-remitting multiple sclerosis. Patients and methods: the results o...

Full description

Bibliographic Details
Main Authors: L. M. Kuzenkova, L. A. Pak, V.M. Studenikin, N. N. Shatilova, B. I. Bursagova, I. E. Smirnova
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2013-09-01
Series:Voprosy Sovremennoj Pediatrii
Subjects:
children
multiple sclerosis
matrix metalloproteinases
cytokines
interferon β-1a
Online Access:https://vsp.spr-journal.ru/jour/article/view/276

Internet

https://vsp.spr-journal.ru/jour/article/view/276

Similar Items